Inflammatory Responses to Acute and Chronic Opioid Exposure in Humans

Stopped early · Not applicable

Conditions studied: Inflammation

In brief

We aim to examine the extent to which inflammation is affected by acute and chronic opioid exposure.

Key facts

Study ID

NCT01749826

Run by

Stanford University

People needed

20

Starts

2010-01-01

Expected to finish

2013-07-01

Last updated by the study team

2019-01-30

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18-60 years old
• Healthy volunteer
• Not allergic to remifentanil

You may not qualify if…

• Patients younger than 18 or older than 70
• Patients unwilling or unable to follow study instructions
• Patients who don't speak English
• Patients who are taking prescription opioid medications (e.g. vicodin, percocet) or are unwilling to refrain from taking anti-inflammatory medications such as Advil or Naproxen during 2 weeks prior to and during the 1 month study

Where it is running

• Stanford University School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.